Quattro Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,705
Closed -$2.81M 104
2026
Q1
$2.81M Buy
5,705
+5
+0.1% +$2.71K 0.85% 38
2025
Q4
$3.31M Hold
5,700
0.99% 29
2025
Q3
$2.77M Hold
5,700
0.88% 29
2025
Q2
$2.31M Hold
5,700
0.81% 33
2025
Q1
$2.84M Hold
5,700
0.97% 27
2024
Q4
$3.28M Hold
5,700
0.85% 27
2024
Q3
$3.42M Hold
5,700
0.96% 28
2024
Q2
$3.15M Hold
5,700
0.82% 29
2024
Q1
$3.31M Buy
5,700
+5,169
+973% +$2.9M 0.94% 28
2023
Q4
$3.03M Sell
531
-5,169
-91% -$2.5M 1.05% 24
2023
Q3
$2.89M Sell
5,700
-136
-2% -$72.5K 1.26% 23
2023
Q2
$3.04M Buy
+5,836
New +$3.15M 1.21% 24

Other funds holding TMO

Quattro Financial Advisors's TMO Position: Q2 2026 in Review

Quattro Financial Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 5,705 shares — an estimated $2.81M sold.

Quattro Financial Advisors first reported a position in TMO in Q2 2023 and held it in 12 quarters. The position peaked at $3.42M in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Quattro Financial Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Quattro Financial Advisors sold 5,705 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.81M.
  • Quattro Financial Advisors first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 12 quarters.
  • Quattro Financial Advisors's Thermo Fisher Scientific position peaked at $3.42M in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Quattro Financial Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.